NLRP3 Activation With Bisphosphonate Use and the Risk of Incident Age-Related Macular Degeneration. Magagnoli J, Cummings T, Hardin JW, Sutton SS, et al. Invest Ophthalmol Vis Sci 2025;66:32.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Magagnoli J, Cummings T, Hardin JW, Sutton SS, et al. NLRP3 Activation With Bisphosphonate Use and the Risk of Incident Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2025;66:32.
PMID: 40094655